CLL
Clinical trials for CLL explained in plain language.
Never miss a new study
Get alerted when new CLL trials appear
Sign up with your email to follow new studies for CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New weapon against tough cancers: first human test of BAFF-R CAR-T therapy begins
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy, called BAFF-R CAR-T, for people with B-cell lymphomas that have come back or not responded to other treatments. The main goals are to check if the treatment is safe and to find the best dose. Researchers will als…
Matched conditions: CLL
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug showdown for Tough-to-Treat blood cancer
Disease control Not yet recruitingThis study aims to find out which of two daily pill treatments works better for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to a previous standard treatment. About 306 participants will be randomly as…
Matched conditions: CLL
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC